Glioblastoma Multiforme Treatment (GBM) Market Report Analysis With Industry Share
                     Glioblastoma Multiforme Treatment (GBM) Market: Introduction
According to the report, the global glioblastoma multiforme treatment (GBM) market was
valued at US$ 1.61 Bn in 2020 and is projected to expand at a CAGR of 8.1% from 2021 to
2028. Glioblastoma multiforme (GBM) is the most common and aggressive type of primary
tumor that can occur in brain or spinal cord. Initially, the symptoms of glioblastoma are
nonspecific,  which  may  include  personality  changes,  nausea,  headaches,  and  symptoms
similar to stroke. Around 133,000 cases of glioblastoma multiforme are reported across the
globe each year.
Advancement of drug delivery technologies is projected to be a major factor driving the
global  glioblastoma  multiforme  treatment  (GBM)  market  during  the  forecast  period.
Moreover, increase in incidence of glioblastoma multiforme treatment (GBM) is anticipated
to propel the global glioblastoma multiforme treatment (GBM) market during the forecast
period.
Request a PDF Brochure 
- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4807
Rise in Burden of Glioblastoma Multiforme Treatment (GBM) to Augment Market
Increase in prevalence of chronic diseases such as cardiovascular diseases, diabetes, and
cancer is expected to drive the demand for glioblastoma multiforme treatment (GBM) in the
next few years. Survival rate of GBM is poor; very few patients survive for 2.5 to 5 years
following diagnosis.  According to data published by the Centers for  Disease Control  and
Prevention (CDC), a national public health agency of the U.S., 90% of adult patients with
GBM die within 24 months after diagnosis. Moreover, the incidence of GBM ranges from
0.59 to 5 per 100,000 individuals, and it is increasing in multiple countries across the globe.
The  figures  above  indicate  that  the  demand  for  GBM  treatment  is  likely  to  increase
exponentially, which, in turn, is projected to augment the global market.
Stuck in a neck-to-neck competition with other brands? Request a custom report on 
Traditional Chinese Herbal Medicine for Face-care Market
Radiation Therapy to be Largest Segment
Radiation therapy was the largest segment of the glioblastoma multiforme market in 2020
due to increased survival rates. Radiation therapy can be highly recommended as the first
treatment  or  combined  with  surgery  and  chemotherapy.  Patients  with  glioblastoma
multiforme  disorder  live  longer  when  given  the  combination  of  radiation  therapy  and
surgery compared to surgery alone. Furthermore, radiation can also be used as the sole
treatment when a glioblastoma tumor is  in an area,  which is  not  suitable for  operative
surgery.
The combination of temozolomide, a medication used to treat glioblastoma multiforme, and
radiotherapy makes the tumor more sensitive to radiation therapy.
Request a Sample of Glioblastoma Multiforme Treatment (GBM) Market: 
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4807
North America to Dominate Global Market
In terms of region, the global glioblastoma multiforme treatment (GBM) market has been
segmented into  North  America,  Europe,  Asia  Pacific,  Latin  America,  and  Middle  East  &
Africa.  North  America  is  projected  to  be  a  highly  lucrative  market  for  glioblastoma
multiforme  treatment  (GBM)  during  the  forecast  period.  Increase  in  presence  of  key
manufacturers such as Pfizer, Inc., Amgen, Inc., and Arbor Pharmaceuticals across the region
is a major factor driving the market in the region.
The availability  of  advanced and cutting-edge healthcare  infrastructure has  aided in the
development of drug repurposing for the treatment of glioblastoma multiforme. Moreover,
favorable regulatory environment is  a  key factor propelling the glioblastoma multiforme
treatment (GBM) market in North America.  A positive legal  and regulatory environment
facilitates the development and early acceptance of GBM medications.
Enquiry before Buying Glioblastoma Multiforme Treatment (GBM) Market Report - 
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=4807
Competition Landscape
The  global  glioblastoma multiforme treatment  (GBM) market  is  fragmented in  terms of
number of players. Key players in the global market include Merck & Co., Inc., F. Hoffmann-
La  Roche  Ltd.,  Pfizer,  Inc.,  Amgen,  Inc.,  Teva  Pharmaceutical  Industries  Ltd.,  Sun
Pharmaceutical  Industries Ltd.,  Arbor Pharmaceuticals,  LLC,  Amneal Pharmaceuticals,  and
Karyopharm Therapeutics,  Inc.,  and Sumitomo Dainippon Pharma Oncology,  Inc.  (Boston
Biomedical, Inc.)
More Trending Reports by Transparency Market Research:
https://www.prnewswire.co.uk/news-releases/technological-breakthroughs-in-liquid-
transfer-system-to-propel-global-aseptic-transfer-system-market-at-cagr-of-7-during-
forecast-period-notes-tmr-study-815987246.html
https://www.prnewswire.com/news-releases/biologics-contract-manufacturing-market-to-
exceed-valuation-of-us-47-3-bn-by-2031--says-tmr-study-301455652.html
https://www.prnewswire.com/news-releases/global-microarray-scanners-market-to-rise-at-
cagr-of-7-4-during-forecast-period-notes-tmr-study-301459293.html
About Us 
Transparency  Market  Research,  a  global  market  research  company  registered  at
Wilmington, Delaware, United States, provides custom research and consulting services. The
firm scrutinizes factors shaping the dynamics of demand in various markets. The insights
and  perspectives  on  the  markets  evaluate  opportunities  in  various  segments.  The
opportunities in the segments based on source, application, demographics, sales channel,
and  end-use  are  analysed,  which  will  determine  growth  in  the  markets  over  the  next
decade.
 
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers, made possible by experienced teams of Analysts,
Researchers, and Consultants. The proprietary data sources and various tools & techniques
we use always reflect the latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary research
techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit 
subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-
TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]